Sort
130,381 grants matching “hiv”
Statistical and Data Management Center (SDMC), Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG)
$3,214,086Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health · UM1 · FY2025 · AI
HIV VACCINE DESIGN AND DEVELOPMENT TEAMS
$3,213,894University Of New South Wales · N01 · FY2000 · AI
CWRU Center for Excellence on the Impact of Substance Use on HIV
$3,213,141Alan David Levine · Case Western Reserve University · P30 · FY2022 · DA
University of Washington Center for AIDS Research
$3,213,108King Kennard Holmes · University Of Washington · P30 · FY2006 · AI
COMMUNITY OUTREACH AND SOCIAL MOBILIZATION FOR PREVENTION OF SEXUAL HIV TRANSMISS
$3,212,502Fikre Estifanos · Population Services International · U2G · FY2010 · PS
UZCHS CTU
$3,210,348Zvavahera Mike Chirenje · University Of California, San Francisco · UM1 · FY2017 · AI
UCLA-CDU CFAR
$3,209,540Jerome A. Zack · University Of California Los Angeles · P30 · FY2023 · AI
COMPREHENSIVE RESOURCES FOR HIV MICROBICIDE AND BIOMEDICAL PREVENTION
$3,208,819James Richardson · Advanced Bioscience Laboratories, Inc. · N01 · FY2015 · AI
UZ-UCSF Clinical Trials Unit
$3,206,808Zvavahera Mike Chirenje · University Of California, San Francisco · U01 · FY2007 · AI
Optimization Of HIV Specific Immune Responses In Vivo
$3,205,924Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
STRENGTHENING PUBLIC SECTOR HIV TESTING,CARE & TREATMENT CAPACITY IN MPUMALANGA,
$3,204,956Sharon White · Reaction Consulting (Pty), Ltd · U2G · FY2010 · PS
Leadership for HIV/AIDS Clinical Trials Networks; Microbicide Trials Network
$3,203,442Benoit Masse · Fred Hutchinson Cancer Research Center · U01 · FY2007 · AI
IMMUNE EPITOPE AND ANALYSIS PROGRAM: Infectious Diseases
$3,202,752Stephen Wilson · La Jolla Institute For Immunology · N01 · FY2021 · AI
HIV Vaccines Design and Dev. Teams Part A - Preventative Vaccine
$3,200,598Children'S Hosp Of Philadelphia · N01 · FY2008 · AI
CoVPN 3008 Multi-Center, Randomized, Efficacy Study of Early vs Deferred Vaccination with COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern - LC GY18
$3,200,000Margaret Juliana McElrath · Fred Hutchinson Cancer Center · UM1 · FY2023 · AI
Synthetic DNA & Novel Env Vaccine for HIV
$3,200,000David B. Weiner · University Of Pennsylvania · U19 · FY2015 · AI
GH13-1310: TECHNICAL ASSISTANCE FOR THE TRANSITION OF COMPREHENSIVE HIV
$3,200,000Ruby N Fayorsey · Columbia University · U2G · FY2014 · GH
Safeguard the household: comprehensive AIDS research
$3,200,000Wits Health Consortium (Pty), Ltd · U19 · FY2002 · AI
Optimizing the Immunogenicity of MVA-Based AIDS Vaccines
$3,199,984Mark B. Feinberg · Emory University · U19 · FY2007 · AI
COMPREHENSIVE RESOURCES FOR HIV MICROBICIDE AND BIOMEDICAL PREVENTION
$3,199,963James Richardson · Advanced Bioscience Laboratories, Inc. · N01 · FY2014 · AI
Women's Interagency HIV Study (WIHS) IV
$3,198,087Kathryn M Anastos · Montefiore Medical Center (Bronx, Ny) · U01 · FY2012 · AI
NIAID SPECIMEN REPOSITORY
$3,197,893Corinne Zeitler · Precision Bioservices, Inc. · N01 · FY2015 · AI
Optimization Of HIV Specific Immune Responses In Vivo
$3,196,577Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
PS10-1001, HIV PREVENTION PROJECTS
$3,196,239Kathy Donner · Arizona State Department Of Hlth Srvcs · U62 · FY2010 · PS
CWRU Center for Excellence on the Impact of Substance Use on HIV
$3,195,848Alan David Levine · Case Western Reserve University · P30 · FY2021 · DA